ORBIMED ADVISORS LLC – Jounce Therapeutics, Inc. Transaction History
ORBIMED ADVISORS LLC portfolio value:
$6.85M
portfolio value
ORBIMED ADVISORS LLC quarter portfolio value change:
-22.77%
quarter
Jounce Therapeutics, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | 0.00% | 0 shares | -2.02M | $2.34 | 2.92M | |
| Q2 2022 | share | Increase | +2.41% | 69K shares | -10.54M | $3.03 | 2.92M |
| Q1 2022 | share | 0.00% | 0 shares | -4.46M | $6.79 | 2.85M | |
| Q4 2021 | share | Increase | +7.69% | 204.3K shares | 4.14M | $8.11 | 2.85M |
| Q3 2021 | share | Increase | +23.67% | 508.2K shares | 5.12M | $7.43 | 2.65M |
| Q2 2021 | share | Increase | +17.76% | 323.8K shares | -4.12M | $6.8 | 2.14M |
| Q1 2021 | share | Increase | 0.00% | 1.82M shares | 18.72M | $10.27 | 1.82M |